Background
Every year, approximately 800 000 deaths that occur in under-five children globally are attributed to invasive pneumococcal disease (IPD) [
1]. The majority of these deaths are reported in Africa, with sub-Saharan Africa (SSA) bearing the greatest burden [
1]. Carriage of
S. pneumoniae is a pre-requisite of IPD, and for carriage to occur, the pneumococcus has to establish itself on the mucosal surfaces of the human nasopharynx [
2].
Carriage plays a key role in pneumococcal transmission within the community [
3]. An individual can carry one or more pneumococcal serotypes at any given time [
4]. Carriage of two or more serotypes is defined as multiple carriage. With the increased availability of highly sensitive serotyping techniques such as the microarray, the full extent of global prevalence of multiple carriage is emerging [
4]. Microarray determines pneumococcal serotype by detecting genes contained within the capsular polysaccharide (CPS) locus, which encode the polysaccharide capsule [
5]. Microarray serotyping can be used to detect (i) multiple carriage; (ii) carriage of other bacterial species; (iii) the absence or presence of particular genes,
e.g. antibiotic resistance genes; (iv) non-typeable serotypes (NTs); as well as (v) novel serotypes by detecting genetic variations at the CPS locus itself [
6].
Multiple carriage is reported to promote genetic recombination, characterised by the acquisition of genetic elements from other microbes through transformation, transduction or conjugative transfer [
7]. Given the pneumococcus is highly transformable and undergoes genetic recombination through horizontal gene transfer [
8], recombination at the CPS locus may result in a change in serotype (capsule switching) [
9] which could lead to vaccine escape [
10]. Therefore, predicting the emergence of vaccine escape in a high IPD burden population such as in Malawi is crucial to understanding the likely long-term public health effect of pneumococcal vaccination.
In November 2011, Malawi introduced PCV13 in the national infant immunisation programme. Conjugate vaccines clearly reduce the burden of vaccine serotype disease and carriage [
11]. However, the increase of non-vaccine serotypes (NVT) in carriage post-vaccination, has led to serotype replacement, which is a major concern [
12]. In settings with a high diversity of pneumococcal carriage, serotype replacement may be exacerbated. Yet despite its importance in pneumococcal evolution, evidence of multiple carriage in Africa has not been well documented.
In the study reported in this article, we investigated the prevalence of multiple carriage and the degree of naturally occurring genetic variation at the CPS loci for important vaccine serotypes in Malawian children from 2008 to 2012, prior to country wide pneumococcal vaccine usage.
Discussion
This study characterised the diversity of pneumococcal carriage in Malawian children by employing a sensitive microarray serotyping method. We observed a much higher diversity of pneumococcal serotypes in Malawian children than reported elsewhere in Africa [
29], where serotyping was by a less sensitive latex agglutination assay. The higher serotype diversity in Malawian children could be attributed high rates of multiple carriage and by the use of a more sensitive method of identification. We also observed that carriage of NVT represented a high proportion (~40 %) of all serotypes circulating in Malawi. These NVTs may ultimately increase in the Malawian population due to serotype replacement following the recent introduction of PCV13 [
11], potentially leading to an increase in NVT IPD cases [
12,
30]. A recent study in Germany has reported an increase of IPD due to NVT serotypes 15A and 23B post PCV13 [
31]. Serotype 15A was detected in our dataset (Fig.
1) and it would be important to monitor the prevalence of serotype 15A and other NVT serotypes in both carriage and IPD in Malawi, post PCV13. We have shown, statistically, that younger children (0–2 years) carried a significantly higher proportion of PCV13 serotypes compared to older children (3–13 years) (
p = 0.028). This supports observations from a recent carriage study in Kathmandu, Nepal where 44.4 % (132/297) of the pneumococcal serotype positive swabs from children aged 0–24 months contained one or more PCV13 serotypes [
32]. This finding suggests that children in this age group are a reservoir of vaccine serotypes. Targeting this group for pneumococcal conjugate vaccination would therefore prevent the spread of vaccine serotypes within the community, thereby ensuring herd immunity.
Carriage of NT strains represented <1 % of all the carried population detected in Malawian children. Three categories of NTs have been reported recently [
33] based on (i) complete deletion of the
cps gene cluster (NT1), (ii) the sole presence of novel surface protein
nspA gene (NT2) at the CPS locus or (iii) the presence of a conserved
aliB-cluster (NT3) at the CPS locus. NTs are usually associated with carriage rather than IPD [
34], which could explain why they are not included in the current vaccine formulations. However, a recent study reported that the highest rates of genetic recombination occurred in NT pneumococcal strains, which suggests their potential importance in genetic exchange events as well as species adaptation [
9]. Although children in Malawi carried only a small proportion of NTs (<1 %), the ability by NTs to recombine readily may be central to the spread of antibiotic resistance, which could have a negative impact on disease control efforts.
At 40 %, we have demonstrated that the rate of multiple carriage among Malawian children is as high as has been reported elsewhere [
4,
35]. Multiple carriage is thought to promote the horizontal gene transfer of antibiotic resistance and virulence genes [
8,
36‐
38], which may contribute to the pathogen adaptation and increased risk of disease in the host. A recent report suggests that multiple carriage may promote co-infection with two or more pneumococcal serotypes [
39]. It is therefore important to understand the dynamics of multiple carriage in a given setting in order to control pneumococcal spread and disease.
We did not find any statistically significant difference in the prevalence of multiple carriage between HIV negative and HIV positive children, which is similar to our recent report in adults [
14]. To date, the effect of HIV infection on pneumococcal carriage is currently not fully understood; hence further studies on much larger datasets need to be conducted to address such questions. Although pneumococcal carriage rates have been shown to decrease with age [
40], this study could not establish the association between age and the prevalence of multiple carriage in children and further studies are therefore recommended.
The polysaccharide capsule is essential for pneumococcal survival and transmission within the host by acting as a barrier to phagocytic killing [
41]. The capsule is also a target for current conjugate vaccine formulations. One of the key mechanisms by which
S. pneumoniae survives the host immune response and the effect of vaccination is to alter its CPS locus, through mutations and genetic recombination. We detected naturally occurring CPS locus variants in vaccine-associated serotypes 6B, 19A and 20. Although multiple carriage is reported to promote genetic recombination through horizontal gene transfer [
42], it is not clear whether this played a role in altering the CPS genes of vaccine serotypes reported here.
Serotype 6B causes 10 % of IPD in young children globally and ranks second after serotype 14 [
24]. In Malawi, serotype 6B is the second most isolated strain from invasive disease in children after serotype 1 [
25]. In our data set, serotype 6B variants were genetically distinct from wildtype 6B serotypes. They demonstrated a significantly high SNPs density (Fig.
4a) and genetic recombination events (Fig.
4b), suggesting carriage of a different lineage of serotype 6B in Malawi. The 6B variants also had novel sequence types, and contained an insertion of the
licD-family phosphotransferase gene (Fig.
5). To ascertain the potential behaviour of the 6B variants under vaccine pressure as the national programme expands, further work in mouse models is recommended.
The
cps locus variant of serotype 19A showed an inversion in the
rmlD gene (Fig.
6). Although inversions do not change the genetic composition of the sequence, recent findings suggest gene inversions may actually lower the expression level of the affected gene, resulting in abnormalities at phenotypic level [
43]. In our setting, the
rmlD gene inversion in the 19A variant may impair the functionality of the whole
rml gene cluster necessary for rhamnose biosynthesis, a component of the polysaccharide capsule. This could lead to the production of an altered 19A capsule, which may not be recognised by the vaccine.
A structural difference of the polysaccharide capsule within serogroup 20 has previously been reported [
44]. This structural difference was due to a truncation and loss of function of the
whaF gene [
44]. The truncation in the
whaF gene correlated with the loss of an αGlc residue in the capsular polysaccharide repeat unit of serotype 20A [
44]. The Malawian serotype 20 variants contained a 716 bp deletion within the
whaF gene (Fig.
7). This deletion would render the
whaF gene non-functional, leading to a loss of an αGlc residue in the capsular polysaccharide repeat unit of the variant. It is therefore likely that the serotype 20 variants circulating in Malawi belong to subtype 20A. However, it is unclear how this deletion affects the ability of the 20 variant to colonise and cause invasive disease, although harbouring an intact allele of the
whaF gene has been associated with invasive strain strains of subtype 20B [
44].
This study had some limitations, which made it impossible to draw some conclusions from the analysis. Because of the limited sample size, we were not able to characterise serotype-specific associations in multiple carriage. To address such limitations, a follow up study with additional samples would be recommended in this population. The microarray technique employed has limited ability to discriminate closely related serotypes, which are detected as a group, however this limitation is common to all known phenotypic and genotypic serotyping methods [
45]. In addition, microarray cannot differentiate NTs from the Mitis-group Streptococci on pneumococcal positive samples [
32], which may lead to an inaccurate estimation of NTs in carriage.
Conclusions
The aim of the study was to characterise the circulating carriage profile and distribution of pneumococcal serotypes in Malawian children, by microarray.
The data clearly showed that Malawian children are exposed to a broad range of serotypes. We have shown that a large proportion of vaccine serotypes were detectable in younger children who represent the primary target group for PCV13. In particular, the high carriage rate of non-vaccine serotypes has the potential to drive serotype replacement with increasing and widespread usage of PCV13, in Malawi, based on the evidence of increasing IPD cases caused by non-vaccine serotypes 15A and 23B in Germany post PCV13 [
31]. Multiple carriage is also common, and has the potential to generate further serotype (CPS) variants through horizontal gene transfer. The variants in this study also reflect naturally occurring variations. Selective pressure from vaccination may exacerbate CPS locus genetic variations and could ultimately promote vaccine escape.
To our knowledge, this is the first study to report such pneumococcal serotype diversity and rates of multiple carriage in Malawian children. The data generated provide a good scientific baseline for measuring the impact of vaccine introduction in Malawi, and also for predicting which serotypes may emerge post vaccination. Such information will be invaluable for vaccine policy.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AWK, KG, RH, SDB and DBE conceived of the study and participated in its design. AWK, BWK and JEC carried out microbial culturing and DNA extractions. AWK and KAG performed the DNA microarray laboratory work. AWK and JH performed microarray data analysis. AWK drafted the manuscript. CC, CM and AWK participated in the sequence alignment, phylogeny and genetic recombination analysis. NF participated in the design of the study and sample selection. NB performed the statistical analysis. All authors read and approved the final manuscript.